AMZN
Amazon.com, Inc.
AMZN has the edge over SBUX overall, supported by stronger valuation and stronger modeled upside.
SBUX
Starbucks Corporation
SBUX offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SBUX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
SBUX's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over SBUX in the historical PE scenario, which offers more potential upside but is not a forecast.
SBUX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $54.72 | -49% |
| Fair | 32x | $71.35 | -33% |
| Forward | 33x | $107 | — |
| Current | 49x | $107 | — |
| Expensive | 78x | $172 | +60% |
Historical ranges are pointers, not guarantees.
SBUX's PE is in its expensive range at 49x. If earnings grow as analysts expect, today's price would be 33x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
SBUX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect SBUX's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SBUX on earnings, with more consistent year-over-year improvement.
SBUX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.23 | +46% |
| Q3 2026 | $2.21 | +36% |
| Q2 2026 | $1.73 | -25% |
| Q1 2026 | $1.31 | -53% |
| Q4 2025 | $1.20 | -61% |
| Q3 2025 | $1.63 | -51% |
| Q2 2025 | $2.32 | -35% |
| Q1 2025 | $2.76 | -24% |
| Q4 2024 | $3.10 | -17% |
SBUX's earnings per share have fallen from their peak: $2.21 over the past year, against $3.74 in late 2023.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over SBUX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over SBUX on profitability, with a higher operating margin.
SBUX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.1B | -4.5% |
| Q2 2026 | $9.3B | -1.4% |
| Q1 2026 | $9.5B | +8.8% |
| Q4 2025 | $9.9B | +5.5% |
| Q3 2025 | $9.6B | +5.5% |
| Q2 2025 | $9.5B | +3.8% |
| Q1 2025 | $8.8B | +2.3% |
| Q4 2024 | $9.4B | -0.3% |
SBUX's revenue grew through 2023 and has held roughly level since: $9.1B last quarter, down 4.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +7.9 points |
| Q2 2026 | 11% | +0.6 points |
| Q1 2026 | 8.7% | +1.8 points |
| Q4 2025 | 9% | -3 points |
| Q3 2025 | 2.9% | -12 points |
| Q2 2025 | 9.9% | -6.8 points |
| Q1 2025 | 6.9% | -6 points |
| Q4 2024 | 12% | -3.8 points |
SBUX's operating margin was 11% last quarter, up 7.9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SBUX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1B | +8.9% |
| Q2 2026 | $1.4B | +211% |
| Q1 2026 | $91.8M | +$389M |
| Q4 2025 | $1.3B | -7.6% |
| Q3 2025 | $925.8M | +26% |
| Q2 2025 | $434.3M | -54% |
| Q1 2025 | -$297.2M | -$144.1M |
| Q4 2024 | $1.4B | -23% |
SBUX has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
SBUX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -400K shares |
| 1 year | +0.3% | +3.6M shares |
| 3 years | -0.7% | -7.9M shares |
| 5 years | -3.6% | -42.1M shares |
| Available history | -4% | -47.6M shares |
SBUX has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $1.3B |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over SBUX on leverage, with a lower net debt burden relative to earnings.
SBUX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 2.8x | Moderate |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 1.8x | Healthy |
SBUX's net debt is about 1.8 years of its operating earnings (EBITDA), down from 2.8 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SBUX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.1 | Neutral |
| Stochastic | 75.9 | Neutral |
SBUX's weekly RSI is 59 (neutral) and its Stochastic is 76 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over SBUX on valuation relative to its sector.
SBUX PE vs Consumer Cyclical Sector
| Metric | SBUX | Sector median | Relative |
|---|---|---|---|
| PE | 49x | 18x | 169% above |
| PE % | 70 | 47 | 23 pts above |
SBUX is trading at 49x earnings, a 169% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
SBUX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $99.4 | 7.9% above |
| 20 week MA | $102.3 | 4.8% above |
| 50 week MA | $98.4 | 9% above |
| 100 week MA | $94.8 | 13% above |
| 200 week MA | $94.9 | 13% above |
SBUX has climbed back above all five of its weekly moving averages, and it's now 13% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
SBUX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $88.1 | $102.0 | +16% |
| 2021 | $102.0 | $112.4 | +10% |
| 2022 | $112.4 | $98.3 | -13% |
| 2023 | $98.3 | $96.0 | -2.3% |
| 2024 | $96.0 | $92.3 | -3.9% |
| 2025 | $92.3 | $85.1 | -7.8% |
| 2026 YTD | $85.1 | $107.3 | +26% |
SBUX has the edge over AMZN on returns for 2026, with the stronger performance.